Novo Nordisk
Anne Goldbech Olsen is a seasoned professional in the field of chemistry and regulatory writing, currently serving as a Regulatory Writer Specialist at Novo Nordisk since August 2016, focusing on submissions for new NDA/MAAs with an emphasis on drug substance processes. Prior experience includes a role as a Senior Scientist at Novo Nordisk, where responsibilities involved chemical process development and regulatory writing, and significant positions at Novozymes, where contributions included organic synthesis of enzyme substrates and project management in enzyme immobilization. Earlier in their career, Anne worked as a Research Scientist at Nuevolution, managing external collaborations and developing DNA compatible chemistries. Anne holds a Ph.D. in Organic Chemistry and a Cand. Scient in Chemistry from Københavns Universitet - University of Copenhagen.
This person is not in any teams
Novo Nordisk
378 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.